Emerging molecular classifications and therapeutic implications for gastric cancer

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Gastric cancer (GC) exhibits high aggressiveness and poor prognosis despite standard treatments.
• Tumor heterogeneity and diverse molecular underpinnings limit the effectiveness of a universal therapeutic approach.
• Recent advancements in genomic and molecular profiling offer new insights into GC's complexity.

Purpose of the Study:

• To review the Cancer Genome Atlas (TCGA) molecular classification of gastric cancer.
• To discuss the implications of this classification for developing novel targeted therapies.
• To highlight the potential for personalized and precise therapeutic strategies in GC treatment.

Main Methods:

• Comprehensive molecular evaluation of primary gastric cancers by the TCGA research network.
• Development of a new molecular classification system for GC based on genetic, epigenetic, and molecular signatures.
• Analysis of four distinct molecular subtypes: Epstein-Barr virus-associated tumors, microsatellite unstable tumors, genomically stable tumors, and tumors with chromosomal instability.

Main Results:

• Identification of four distinct molecular subtypes of gastric cancer.
• Demonstration of GC's molecular heterogeneity.
• Establishment of a foundation for understanding subtype-specific therapeutic vulnerabilities.

Conclusions:

• The TCGA molecular classification provides a framework for understanding GC heterogeneity.
• This classification holds significant promise for guiding the development of targeted therapies.
• Personalized treatment strategies based on molecular subtypes are crucial for improving outcomes in gastric cancer.